Business Wire

Business Wire is the global leader in news release distribution and regulatory disclosure. Business Wire delivers news and multimedia directly into editorial systems and leading online news platforms and is a trusted source for news organisations, journalists, investment professionals and regulatory authorities.

Results: 1453-1464 of 20338

Eldridge Sponsored Fund Provides €85 Million Loan for the Refinancing of Segreen Business Park

AI: The New Insider Threat Facing Organizations

Zuper and Vonage Reimagine Network Connectivity for Skilled Trades with Quality on Demand

Ascensia Diabetes Care Appoints Peter Bodlund as President and Chief Executive Officer

Industrial Decarbonization: Calderion, WenCo and Terravent Invest in Graforce to Scale Plasma Pyrolysis Globally

Mevion Medical Systems Announces CE Marking of the MEVION S250-FIT™ Proton Therapy System, Expanding Global Access to Compact Proton Therapy

Bureau Veritas: Sector-Leading Organic Revenue Growth of 6.5% in FY 2025

Galderma Announces Triple Approval of New State-of-the-Art Restylane® Syringe in the EU, the U.S., and Canada, Reaffirming the Company’s Position at the Forefront of Injectable Aesthetics

Business Wire

Eldridge Sponsored Fund Provides €85 Million Loan for the Refinancing of Segreen Business Park

AI: The New Insider Threat Facing Organizations

Zuper and Vonage Reimagine Network Connectivity for Skilled Trades with Quality on Demand

Ascensia Diabetes Care Appoints Peter Bodlund as President and Chief Executive Officer

Industrial Decarbonization: Calderion, WenCo and Terravent Invest in Graforce to Scale Plasma Pyrolysis Globally

Mevion Medical Systems Announces CE Marking of the MEVION S250-FIT™ Proton Therapy System, Expanding Global Access to Compact Proton Therapy

Bureau Veritas: Sector-Leading Organic Revenue Growth of 6.5% in FY 2025

Galderma Announces Triple Approval of New State-of-the-Art Restylane® Syringe in the EU, the U.S., and Canada, Reaffirming the Company’s Position at the Forefront of Injectable Aesthetics

Azafaros Announces Publication of Preclinical Efficacy Data with Nizubaglustat in GM2 Gangliosidosis

Luxfer Delivers Strong Full-Year 2025 Profitability and Cash Generation

IGI Reports Fourth Quarter and Full Year 2025 Unaudited Financial Results and Declares Ordinary Common Share Dividend

Alkermes to Present at the TD Cowen 46th Annual Health Care Conference